Manske Wealth Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$521K Buy
10,812
+192
+2% +$8.95K 0.15% 117
2025
Q4
$515K Sell
10,620
-251
-2% -$12.4K 0.15% 112
2025
Q3
$513K Sell
10,871
-157
-1% -$7.58K 0.16% 108
2025
Q2
$533K Hold
11,028
0.18% 106
2025
Q1
$612K Buy
11,028
+387
+4% +$20.9K 0.23% 89
2024
Q4
$513K Buy
+10,641
New +$541K 0.2% 95

Other funds holding SNY

Manske Wealth Management's SNY Position: Q1 2026 in Review

Manske Wealth Management increased its Sanofi (SNY) stake by 1.8% in Q1 2026, buying an estimated $8.95K and bringing the position to 10,812 shares worth $521K. The position accounts for 0.15% of the portfolio, ranked #117.

Manske Wealth Management first reported a position in SNY in Q4 2024 and has held it in 6 quarters since. The position peaked at $612K in Q1 2025. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Manske Wealth Management held 10,812 shares of Sanofi worth $521K as of Q1 2026.
  • Manske Wealth Management bought 192 Sanofi shares in Q1 2026, an estimated $8.95K.
  • Sanofi made up 0.15% of Manske Wealth Management's portfolio in Q1 2026, its #117 holding.
  • Manske Wealth Management first reported a position in Sanofi in Q4 2024 and has held it in 6 quarters since.
  • Manske Wealth Management's Sanofi position peaked at $612K in Q1 2025.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Manske Wealth Management's 13F filing for Q1 2026, filed 30 Apr 2026.